Lucid Diagnostics receives VA contract for esophageal cancer test
Go back to Lucid Diagnostics receives VA contract for esophageal cancer test| (NASDAQ: LUCD) | Delayed: 1.01 +0.02 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.99 | 52 Week High | $ | |||
| Open | $0.98 | 52 Week Low | $ | |||
| Day High | $1.03 | P/E | N/A | |||
| Day Low | $0.97 | EPS | $ | |||
| Volume | 1,140,485 | |||||
| (NASDAQ: PAVM) | Delayed: 5.10 +0.04 (0.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.06 | 52 Week High | $15.24 | |||
| Open | $5.04 | 52 Week Low | $10.50 | |||
| Day High | $5.29 | P/E | N/A | |||
| Day Low | $4.91 | EPS | $0.00 | |||
| Volume | 22,093 | |||||
